•  
  •  
  •  
  •  

2025-12-02 19:22:59

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hexaware Celebrates 22 Wins at 2025 MarCom Awards, Scoring in Every Entered Category
  • R.P.P Infra Projects Ltd wins new orders worth Rs. 25.99 Crores
  • IRFC returns to the External Commercial Borrowing market after more than three years for raising JPY equivalent USD 300 million
  • Neetu Yoshi Ltd receives orders worth Rs. 18.63 crores
  • SUGS Lloyd Ltd receives NOA form Punjab State Power Corporation Ltd

Keywords Selected:  Liraglutide

Stock Report

  • Lupin Launches Liraglutide Injection in the United States
  • Lupin receives US FDA Approvals for Liraglutide and Glucagon Injectable Products
  • Biocon Limited launches its Glucagon-like peptide-1 (GLP -1), Liraglutide, in the United Kingdom
  • Biocon Ltd signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda® in Mexico with Medix
  • Biocon's European partner Zentiva receives approval from UK MHRA for Liraglutide
  • Biocon is the first generics Company to obtain approval for diabetes drug, Liraglutide, in the U.K.
  • Glenmark is the first to launch Biosimilar of Popular Anti‐Diabetic Drug, Liraglutide, in India
  • Biocon Limited enters into a commercialization agreement with Zentiva in Europe

Latest Post

  • Hexaware Celebrates 22 Wins at 2025 MarCom Awards, Scoring in Every Entered Category
  • R.P.P Infra Projects Ltd wins new orders worth Rs. 25.99 Crores
  • IRFC returns to the External Commercial Borrowing market after more than three years for raising JPY equivalent USD 300 million
  • Neetu Yoshi Ltd receives orders worth Rs. 18.63 crores
  • SUGS Lloyd Ltd receives NOA form Punjab State Power Corporation Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024